Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis
The World Health Organization recommends pre-exposure prophylaxis (PrEP) for individuals at substantial risk of HIV infection. The aim of this analysis is to quantify the individual risk of HIV infection over time, using a large database of high-risk individuals (<i>n</i> = 5583). We use...
Saved in:
Main Authors: | Maria Garcia-Cremades (Author), Craig W. Hendrix (Author), Priya Jayachandran (Author), Natasha Strydom (Author), Leah Jarlsberg (Author), Robert Grant (Author), Connie L. Celum (Author), Michael Martin (Author), Jared M. Baeten (Author), Jeanne Marrazzo (Author), Peter Anderson (Author), Kachit Choopanya (Author), Suphak Vanichseni (Author), David V. Glidden (Author), Radojka M. Savic (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Mechanistic In Vivo/Ex Vivo Pharmacokinetic‐Pharmacodynamic Model of Tenofovir for HIV Prevention
by: Priya Jayachandran, et al.
Published: (2021) -
Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women
by: Maria Pyra, et al.
Published: (2019) -
Perceptions of pregnancy occurring among HIV-serodiscordant couples in Kenya
by: Grace Kimemia, et al.
Published: (2019) -
Treatment outcome of newly detected pulmonary Tuberculosis in HIV-seropositive and HIV-seronegative patients
by: Virendra C Patil, et al.
Published: (2014) -
Outcomes of Hysterectomy in HIV-Seropositive Women Compared to Seronegative Women
by: Jennifer Franz, et al.
Published: (2005)